A5109673647- Colorectal and Anal Carcinomas
- Genetic factors in colorectal cancer
- Gastrointestinal Tumor Research and Treatment
- Metastasis and carcinoma case studies
- Colorectal Cancer Screening and Detection
- Colorectal Cancer Treatments and Studies
- Neuroendocrine Tumor Research Advances
- Cancer Immunotherapy and Biomarkers
- Multiple and Secondary Primary Cancers
Nanjing University of Chinese Medicine
2023-2025
Jiangsu Province Hospital
2023
Colorectal cancer (CRC) is the third most prevalent form of worldwide. Among patients with CRC, colorectal liver metastasis (CRLM) foremost direct contributor to mortality. In recent years, immunotherapy has swiftly risen prominence as a vital approach for treating range solid tumors, including CRC. We present unique case patient suffering from CRLM, goal offering an insightful example and relevant references treatment CRLM. report who experienced after undergoing successful surgical removal...
The annual rise in gastrointestinal cancer cases is evident, yet the occurrence of multiple primary malignancies remains comparatively uncommon. In recent years, immunotherapy has swiftly emerged as leading treatment for several solid tumors, including cancers. Single treatments might be ineffective, necessitating need comprehensive integrative medicine. This study reports a case cancers, colorectal and gastric Diverse systemic treatments, like capecitabine, combination capecitabine...
In 2022, esophageal cancer (EC) was the eleventh most frequently diagnosed and seventh leading cause of cancer-related deaths worldwide. Nonetheless, prevalence burden EC in Asian countries have been little studied. This study investigated prevalence, incidence, five East from 1990 to 2021. We retrieved data Global Burden Diseases, Injuries, Risk Factors Study (GBD) 2021 on mortality, years lived with disability (YLDs), life lost (YLLs), disability-adjusted (DALYs) associated The...
Duodenal squamous cell carcinoma is an exceedingly rare occurrence among gastrointestinal malignancies, and its diagnosis treatment are not well understood. In this report, we present a case of duodenal with liver adrenal metastasis. The patient was treated gemcitabine S-1, achieving progression-free survival (PFS) 7 months overall (OS) 9 months. Additionally, review the features approaches reported in previous cases primary carcinoma. Clearly, further reports, such as ours, can contribute...
The Guidelines for prevention and treatment of colorectal adenoma with integrated Chinese western medicine are put forward by Nanjing University Medicine approved China Association Medicine. According to the formulation processes methods relevant clinical practice guidelines, experts in methodology were organized discuss key problems be addressed adenoma(CRA) provided answers following evidence-based method, so as provide guidance decision-making. CRA is major precancerous disease cancer....